Medtronic Vascular
Clinical trials sponsored by Medtronic Vascular, explained in plain language.
-
New stent aims to keep heart arteries open longer
Disease control OngoingThis study tests a special stent coated with a drug called zotarolimus to treat people with blocked heart arteries. The stent is placed during a procedure to open the artery and slowly releases medication to prevent re-blockage. About 591 participants in China are being followed …
Phase: NA • Sponsor: Medtronic Vascular • Aim: Disease control
Last updated Jun 23, 2026 11:59 UTC
-
New stent shows promise in unclogging heart arteries
Disease control OngoingThis study tests a newer drug-coated stent (Resolute Onyx) against an older one (Resolute Integrity) in 550 people with blocked heart arteries in China. The goal is to see if the new stent works better at keeping arteries open after angioplasty. Participants receive one of the tw…
Phase: NA • Sponsor: Medtronic Vascular • Aim: Disease control
Last updated Jun 18, 2026 11:50 UTC
-
Kidney nerve treatment shows promise for stubborn high blood pressure
Disease control OngoingThis study tests a procedure called renal denervation, which uses a device to calm overactive nerves in the kidneys that can raise blood pressure. About 1,900 adults with uncontrolled high blood pressure will receive the treatment and be followed for years to see if it safely and…
Phase: NA • Sponsor: Medtronic Vascular • Aim: Disease control
Last updated Jun 12, 2026 12:07 UTC